BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 3122217)

  • 1. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Janssen JW; Steenvoorden AC; Lyons J; Anger B; Böhlke JU; Bos JL; Seliger H; Bartram CR
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9228-32. PubMed ID: 3122217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in ras genes in myelocytic leukemias and myelodysplastic syndromes.
    Bartram CR
    Blood Cells; 1988; 14(2-3):533-8. PubMed ID: 3067784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent mutations in two different ras genes in acute myelocytic leukemias.
    Janssen JW; Lyons J; Steenvoorden AC; Seliger H; Bartram CR
    Nucleic Acids Res; 1987 Jul; 15(14):5669-80. PubMed ID: 3475676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation in TET2 in myeloid cancers.
    Delhommeau F; Dupont S; Della Valle V; James C; Trannoy S; Massé A; Kosmider O; Le Couedic JP; Robert F; Alberdi A; Lécluse Y; Plo I; Dreyfus FJ; Marzac C; Casadevall N; Lacombe C; Romana SP; Dessen P; Soulier J; Viguié F; Fontenay M; Vainchenker W; Bernard OA
    N Engl J Med; 2009 May; 360(22):2289-301. PubMed ID: 19474426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.
    Farr CJ; Saiki RK; Erlich HA; McCormick F; Marshall CJ
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1629-33. PubMed ID: 3278322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
    Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
    Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia.
    Sheng XM; Kawamura M; Ohnishi H; Ida K; Hanada R; Kojima S; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
    Leuk Res; 1997 Aug; 21(8):697-701. PubMed ID: 9379676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of N-ras oncogene in myelodysplastic syndromes and leukemias detected by polymerase chain reaction.
    Mano H; Ishikawa F; Hirai H; Takaku F
    Jpn J Cancer Res; 1989 Feb; 80(2):102-6. PubMed ID: 2498243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of ras gene mutations and methylation state in human leukemias.
    Browett PJ; Norton JD
    Oncogene; 1989 Aug; 4(8):1029-36. PubMed ID: 2668844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation.
    Padua RA; Carter G; Hughes D; Gow J; Farr C; Oscier D; McCormick F; Jacobs A
    Leukemia; 1988 Aug; 2(8):503-10. PubMed ID: 3166076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemias.
    Ludwig L; Janssen JW; Schulz AS; Bartram CR
    Leukemia; 1993 Jul; 7(7):1058-60. PubMed ID: 8321021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes.
    Lyons J; Janssen JW; Bartram C; Layton M; Mufti GJ
    Blood; 1988 Jun; 71(6):1707-12. PubMed ID: 3285909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myelodysplastic/myeloproliferative disorders: the interface.
    Bennett JM
    Hematol Oncol Clin North Am; 2003 Oct; 17(5):1095-100, v. PubMed ID: 14560776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ras oncogene activation and occupational exposures in acute myeloid leukemia.
    Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
    J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.
    Euba B; Vizmanos JL; García-Granero M; Aranaz P; Hurtado C; Migueliz I; Novo FJ; García-Delgado M
    Leuk Lymphoma; 2012 Jun; 53(6):1230-3. PubMed ID: 22080757
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
    Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
    Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
    Larsson N; Billström R; Lilljebjörn H; Lassen C; Richter J; Ekblom M; Fioretos T
    Cancer Genet Cytogenet; 2010 Jun; 199(2):89-95. PubMed ID: 20471511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia.
    Tobal K; Pagliuca A; Bhatt B; Bailey N; Layton DM; Mufti GJ
    Leukemia; 1990 Jul; 4(7):486-9. PubMed ID: 2142747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of ras gene activation in myeloid leukemic cells.
    Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
    Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.